These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 7138678

  • 21. Hypoalbuminemia-related platelet hypersensitivity in two dogs with nephrotic syndrome.
    Green RA, Russo EA, Greene RT, Kabel AL.
    J Am Vet Med Assoc; 1985 Mar 01; 186(5):485-8. PubMed ID: 2982777
    [Abstract] [Full Text] [Related]

  • 22. [Platelet hyperaggregation and plasma hypercoagulability associated with normal antithrombin III and platelet factor 3 deficiency in the nephrotic syndrome in children].
    Cutcudache C, Boldescu G, Antal C, Chirică A.
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984 Mar 01; 36(1):57-66. PubMed ID: 6145206
    [No Abstract] [Full Text] [Related]

  • 23. Clinical studies on plasma antithrombin III using an antiserum prepared in our laboratories.
    Cucuianu M, Cristea A, Vonica A, Lascu I.
    Med Interne; 1988 Mar 01; 26(3):191-7. PubMed ID: 3187359
    [Abstract] [Full Text] [Related]

  • 24. Protein C and protein S in pediatric nephrotic patients.
    Yermiahu T, Shalev H, Landau D, Dvilansky A.
    Sangre (Barc); 1996 Apr 01; 41(2):155-7. PubMed ID: 9045358
    [Abstract] [Full Text] [Related]

  • 25. Antithrombin III level in children with nephrotic syndrome, its correlation to thromboembolic complications, and serum albumin level.
    Hussein SK, Mohammed AH, Mohammed RA, Abdelghafar H.
    Saudi J Kidney Dis Transpl; 2021 Apr 01; 32(5):1283-1288. PubMed ID: 35532697
    [Abstract] [Full Text] [Related]

  • 26. Serum albumin levels anticipate antithrombin III activities before and after antithrombin III agent in critical patients with disseminated intravascular coagulation.
    Aibiki M, Fukuoka N, Umakoshi K, Ohtsubo S, Kikuchi S.
    Shock; 2007 Feb 01; 27(2):139-44. PubMed ID: 17224787
    [Abstract] [Full Text] [Related]

  • 27. Haemostatic parameters in childhood nephrotic syndrome. (Is there any difference in protein C levels between steroid sensitive and resistant groups?).
    Yalçinkaya F, Tümer N, Gorgani AN, Ekim M, Cakar N.
    Int Urol Nephrol; 1995 Feb 01; 27(5):643-7. PubMed ID: 8775051
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Plasma and urinary heparin cofactor II levels in patients with nephrotic syndrome.
    Grau E, Oliver A, Félez J, Barceló P, Fernandez C, Ballarin JA, Fontcuberta J, Rutllant ML.
    Thromb Haemost; 1988 Oct 31; 60(2):137-40. PubMed ID: 3217913
    [Abstract] [Full Text] [Related]

  • 31. Acquired antithrombin III deficiency and thrombosis in the nephrotic syndrome.
    Kauffmann RH, Veltkamp JJ, Van Tilburg NH, Van Es LA.
    Am J Med; 1978 Oct 31; 65(4):607-13. PubMed ID: 707521
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Incidence of proteinuria and nephrotic syndrome in renal vein occlusion caused by a tumor].
    Steurer J, Pouliadis G, Hauri D, Siegenthaler W, Kuhlmann U.
    Schweiz Med Wochenschr; 1980 Jan 31; 110(1):23-6. PubMed ID: 7361078
    [Abstract] [Full Text] [Related]

  • 34. [Comparative evaluation of 3 methods of study of antithrombin III].
    Nakabanda A, Katsadze IuL, Kotovshchikova MA.
    Lab Delo; 1984 Jan 31; (5):276-9. PubMed ID: 6204109
    [No Abstract] [Full Text] [Related]

  • 35. [Favorable effects of epsilon-aminocaproic acid on the children with nephrotic syndrome and Schonlein-Henoch syndrome treated with corticosteroids].
    Prandota J, Panków-Prandota L, Rotter A, Kotecki L.
    Pol Merkur Lekarski; 1996 Oct 31; 1(4):241-5. PubMed ID: 9156934
    [Abstract] [Full Text] [Related]

  • 36. Mechanisms of the development of acquired antithrombin III deficiency in the experimental nephrotic syndromes.
    Bashkov GV, Kalishevskaya TM, Strukova SM.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988 Oct 31; 115(3):324-8. PubMed ID: 2465224
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Natural coagulation inhibitors; antithrombin III, protein C, protein S in children with hypercoagulation due to nephrotic syndrome].
    Wygledowska G, Grygalewicz J, Matuszewska E.
    Med Wieku Rozwoj; 2001 Oct 31; 5(4):377-88. PubMed ID: 12004145
    [Abstract] [Full Text] [Related]

  • 40. [Low blood zinc levels in children with nephrotic syndrome (author's transl)].
    Bensman A, Morgant G, Hasaerts D, Lasfargues G.
    Nouv Presse Med; 1981 Dec 19; 10(46):3779-81. PubMed ID: 7322912
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.